drugset / Trial / NCT00847405

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

NCT00847405

Phase 1 Completed 28 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The objective of this study is to compare the rate and extent of absorption of sumatriptan from a test formulation of Sumatriptan Succinate 100 mg Tablets versus the reference Imitrex® 100 mg Tablets under fasting conditions.

Timeline

Start
2003-03
Primary completion
2003-03
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sumatriptan Unknown 100 mg

Indications

No indication recorded.